vs
Royalty Pharma plc(RPRX)与世纪互联(VNET)财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是世纪互联的1.7倍($622.0M vs $362.7M),Royalty Pharma plc净利率更高(34.4% vs -10.7%,领先45.1%),过去两年世纪互联的营收复合增速更高(17.4% vs 4.6%)
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
VNET Group即世纪互联,是中国领先的第三方中立数据中心服务商,提供机柜托管、云基础设施、混合云部署及网络管理等解决方案,服务覆盖科技、金融、零售等多领域企业客户,为企业数字化运营提供稳定的算力与网络支撑。
RPRX vs VNET — 直观对比
营收规模更大
RPRX
是对方的1.7倍
$362.7M
净利率更高
RPRX
高出45.1%
-10.7%
两年增速更快
VNET
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $622.0M | $362.7M |
| 净利润 | $214.2M | $-38.7M |
| 毛利率 | — | 20.9% |
| 营业利润率 | 62.4% | 0.5% |
| 净利率 | 34.4% | -10.7% |
| 营收同比 | 4.8% | — |
| 净利润同比 | 2.9% | — |
| 每股收益(稀释后) | $0.49 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RPRX
VNET
| Q4 25 | $622.0M | — | ||
| Q3 25 | $609.3M | $362.7M | ||
| Q2 25 | $578.7M | — | ||
| Q1 25 | $568.2M | $309.5M | ||
| Q4 24 | $593.6M | — | ||
| Q3 24 | $564.7M | $302.2M | ||
| Q2 24 | $537.3M | $274.4M | ||
| Q1 24 | $568.0M | $262.9M |
净利润
RPRX
VNET
| Q4 25 | $214.2M | — | ||
| Q3 25 | $288.2M | $-38.7M | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $238.3M | $-2.4M | ||
| Q4 24 | $208.2M | — | ||
| Q3 24 | $544.0M | $-2.1M | ||
| Q2 24 | $102.0M | $-1.1M | ||
| Q1 24 | $4.8M | $-22.0M |
毛利率
RPRX
VNET
| Q4 25 | — | — | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 25.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 21.6% |
营业利润率
RPRX
VNET
| Q4 25 | 62.4% | — | ||
| Q3 25 | 70.1% | 0.5% | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 94.0% | 0.1% | ||
| Q4 24 | 60.9% | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | 50.2% | 0.2% | ||
| Q1 24 | -13.0% | 0.2% |
净利率
RPRX
VNET
| Q4 25 | 34.4% | — | ||
| Q3 25 | 47.3% | -10.7% | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 41.9% | -0.8% | ||
| Q4 24 | 35.1% | — | ||
| Q3 24 | 96.3% | -0.7% | ||
| Q2 24 | 19.0% | -0.4% | ||
| Q1 24 | 0.8% | -8.4% |
每股收益(稀释后)
RPRX
VNET
| Q4 25 | $0.49 | — | ||
| Q3 25 | $0.67 | — | ||
| Q2 25 | $0.07 | — | ||
| Q1 25 | $0.55 | — | ||
| Q4 24 | $0.46 | — | ||
| Q3 24 | $1.21 | — | ||
| Q2 24 | $0.23 | — | ||
| Q1 24 | $0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $492.1M |
| 总债务越低越好 | $9.0B | — |
| 股东权益账面价值 | $9.7B | $890.8M |
| 总资产 | $19.6B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.92× | — |
8季度趋势,按日历期对齐
现金及短期投资
RPRX
VNET
| Q4 25 | $618.7M | — | ||
| Q3 25 | $938.9M | $492.1M | ||
| Q2 25 | $631.9M | — | ||
| Q1 25 | $1.1B | $544.3M | ||
| Q4 24 | $929.0M | — | ||
| Q3 24 | $950.1M | $219.5M | ||
| Q2 24 | $1.8B | $247.2M | ||
| Q1 24 | $843.0M | $246.9M |
总债务
RPRX
VNET
| Q4 25 | $9.0B | — | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.0B | — | ||
| Q1 25 | $7.6B | — | ||
| Q4 24 | $7.6B | — | ||
| Q3 24 | $7.6B | $1.2B | ||
| Q2 24 | $7.6B | — | ||
| Q1 24 | $6.1B | — |
股东权益
RPRX
VNET
| Q4 25 | $9.7B | — | ||
| Q3 25 | $9.6B | $890.8M | ||
| Q2 25 | $9.5B | — | ||
| Q1 25 | $9.8B | $927.8M | ||
| Q4 24 | $10.3B | — | ||
| Q3 24 | $10.3B | $902.9M | ||
| Q2 24 | $9.8B | $900.6M | ||
| Q1 24 | $9.9B | $895.1M |
总资产
RPRX
VNET
| Q4 25 | $19.6B | — | ||
| Q3 25 | $19.3B | $6.1B | ||
| Q2 25 | $18.3B | — | ||
| Q1 25 | $17.6B | $5.4B | ||
| Q4 24 | $18.2B | — | ||
| Q3 24 | $18.0B | $4.3B | ||
| Q2 24 | $17.7B | $4.0B | ||
| Q1 24 | $16.1B | $3.9B |
负债/权益比
RPRX
VNET
| Q4 25 | 0.92× | — | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | 1.28× | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $827.1M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-193.1M |
| 自由现金流率自由现金流/营收 | — | -53.2% |
| 资本支出强度资本支出/营收 | — | 84.6% |
| 现金转化率经营现金流/净利润 | 3.86× | — |
| 过去12个月自由现金流最近4个季度 | — | $-589.7M |
8季度趋势,按日历期对齐
经营现金流
RPRX
VNET
| Q4 25 | $827.1M | — | ||
| Q3 25 | $702.6M | $113.8M | ||
| Q2 25 | $364.0M | — | ||
| Q1 25 | $596.1M | $27.0M | ||
| Q4 24 | $742.5M | — | ||
| Q3 24 | $703.6M | $108.3M | ||
| Q2 24 | $658.2M | $55.8M | ||
| Q1 24 | $664.6M | $37.1M |
自由现金流
RPRX
VNET
| Q4 25 | — | — | ||
| Q3 25 | — | $-193.1M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-220.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-95.0M | ||
| Q2 24 | — | $-81.6M | ||
| Q1 24 | — | $-102.2M |
自由现金流率
RPRX
VNET
| Q4 25 | — | — | ||
| Q3 25 | — | -53.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -71.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -31.4% | ||
| Q2 24 | — | -29.8% | ||
| Q1 24 | — | -38.9% |
资本支出强度
RPRX
VNET
| Q4 25 | — | — | ||
| Q3 25 | — | 84.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 79.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 67.3% | ||
| Q2 24 | — | 50.1% | ||
| Q1 24 | — | 53.0% |
现金转化率
RPRX
VNET
| Q4 25 | 3.86× | — | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 12.06× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 3.57× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 6.45× | — | ||
| Q1 24 | 139.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
VNET
暂无分部数据